Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA

Boehringer Ingelheim

Status: Completed

Conditions: Venous Thromboembolism

Study type: Observational

Funder types: Industry

Identifiers

NCT01139658

1160.102

Details and patient eligibility

About

Observational cohort study on the prevention of venous thromboembolic events after elective orthopaedic surgery for Total Knee Replacement or Total Hip Replacement iin patients treated with PRADAXA to evaluate the efficacy ant safety of Pradaxa in real-life conditions

Enrollment: 1,676 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients treated with Pradaxa undergoing surgery for Total Knee Replacement or Total Hip Replacement
2. Patients 18 years of age or older at the time of recruitment

Exclusion criteria

1. Patients presenting contraindication to prescription of Pradaxa
2. Patients in whom long term Anti vitamin K treatment is indicated

Trial design

1,676 participants in 1 patient group

All comers